THE INTELLIGENCE-1 STUDY (completed study)

INTELLIGENCE-1 is a non-interventional trial to validate the diagnostic accuracy of HemoSpec in the diagnosis of sepsis. HemoSpec is a device that integrates information of whole blood cell count, Raman spectra of circulating white blood cells and serum proteins.

Study title: “INTEgration of clinicaL and Laboratory Information to GENerate technological advanCE for the diagnosis of sepsis”
ClinicalTrials.gov NCT03306186
Duration: October 2017-March 2018
Study phase: II
Study sites: 5 sites in Greece
Enrolled patients: 173